Pinsent Masons advises Retroscreen on £25.5 million fund raising
14 Jun 2013 | 04:47 pm | 1 min. read
International law firm Pinsent Masons has advised antiviral anti-viral clinical trial specialist, Retroscreen, on its conditional placing raising a total of £25.5 million.
The firm, lead by corporate partner Russell Booker and associate Mark Stephens advised the AIM-listed company which is expected to use the funds to build a new clinical division.
Retroscreen is a virology healthcare business which provides clinical and pre-clinical analytical services for flu and cold antiviral products to global pharmaceutical and biotechnology organisations.
Partner Russell Booker said: "We are very pleased to have strengthened our relationship with Retroscreen and work with them again to raise funds for a number of high profile projects. The company has experienced significant growth since listing on AIM and it is testament to our expertise that we have been instructed to guide the team through some significant milestones."
Retroscreen turned to Pinsent Masons last year to advise on its listing on the London Stock Exchange (LSE) AIM market raising £15 million. Since listing on AIM the company has focused on developing its services opening a new Flucamp screening centre and viral study programme. In 2012, Retroscreen reported a 237 per cent revenue growth up to £14.4m.
Retroscreen chief executive, Kym Denny, said: "We are delighted to have successfully raised these funds through both existing and new shareholders. We thank our existing shareholders for their continued support and encouragement, and we welcome our new shareholders to the share register. The board looks forward to investing the proceeds of the placing in building the AD-VCM and Discovery Division. It is a very exciting time at Retroscreen and lots to achieve."
Latest press releases
Show me all press releasesPinsent Masons advises Peel Hunt on EnQuest's strategic reverse takeover
Pinsent Masons is advising Peel Hunt in its capacity of Sponsor in London Stock Exchange-listed EnQuest’s proposed $833 million acquisition of participating interests in four offshore production sharing contracts in Malaysia.
Pinsent Masons advises Sammons Enterprises on the disposal of Briggs Equipment
Multinational law firm Pinsent Masons has advised Sammons Enterprises on the disposal of materials handling equipment provider Briggs Equipment UK to pension capital firm IFM Investors. After receiving the required regulatory clearances, the deal formally completed on 2 June.
Pinsent Masons appoints structured finance partner Thomas Shen in London
Multinational law firm Pinsent Masons has appointed Thomas Shen as a Partner in its Structured Finance team, based in London.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises Sammons Enterprises on the disposal of Briggs Equipment
Multinational law firm Pinsent Masons has advised Sammons Enterprises on the disposal of materials handling equipment provider Briggs Equipment UK to pension capital firm IFM Investors. After receiving the required regulatory clearances, the deal formally completed on 2 June.
Pinsent Masons advises on sale of VLocker to Venu+
Multinational law firm Pinsent Masons has advised on the sale of VLocker, a global leader in the design, manufacture, installation and management of electronic locker systems, to Venu+, a United States‑based portfolio company of private equity fund ZCG.
Pinsent Masons advises INDY Cinema on its acquisition by VERSANT
Multinational law firm Pinsent Masons has advised international cinema technology business INDY Cinema (INDY) on its acquisition by New York-based VERSANT, an industry-changing media and entertainment company.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]